Searchable abstracts of presentations at key conferences in endocrinology

ea0090p312 | Calcium and Bone | ECE2023

Teriparatide in the challenging management of hypoparathyroidism, our experience in one medical center in Argentina

Mallea-Gil Susana , Sanchez Yamila , Coca Bibiana , Lopez Cindy , de los Angeles Sosa Maria , Sankowicz Silvina , Marta Aparicio Maria , Ballarino Carolina

Hypoparathyroidism is an endocrine deficiency whose substitution treatment with PTH 1-84 is only available in compassionate use in Argentina. There is a subgroup of patients in which the conventional therapy with calcium, calcitriol, phosphorous chelators, magnesium and diuretics does not reach an adequate clinical and/or biochemical compensation. Although teriparatide (PTH 1-34) is not approved for patients with hypoparathyroidism, it is a plausible therapeutic resource.<...